Corpus Intelligence IC Memo — QUAKERTOWN COMMUNITY HOSPITAL 2026-04-27 00:11 UTC
IC Memo — QUAKERTOWN COMMUNITY HOSPITAL
Investment Committee Memorandum | PA | 86 beds | Grade C | EBITDA uplift $10.8M
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 390035

QUAKERTOWN COMMUNITY HOSPITAL

LOCATIONBUCKS, PA·BEDS86·AS OFApril 27, 2026
C
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

QUAKERTOWN COMMUNITY HOSPITAL is a 86-bed suburban community hospital in BUCKS, PA with $146.5M in net patient revenue and a 5.0% operating margin. The hospital serves a payer mix of 33.2% Medicare, 6.1% Medicaid, and 60.7% commercial.

Thesis: Turnaround. Our ML models identify $10.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.0% to 12.4% (+736bps).

Net Revenue HCRIS$146.5M
Current EBITDA COMPUTED$7.3M
Operating Margin COMPUTED5.0%
Occupancy HCRIS81.5%
Revenue / Bed COMPUTED$1.7M
Net-to-Gross HCRIS11.5%
Distress Probability ML38.9%

2. Market Context & Competitive Position

225
PA Hospitals
-4.4%
State Median Margin
101
Comparable Hospitals

PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of 5.0% places it above the state median. Among 101 size-comparable peers (43-172 beds), the median margin is -4.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (43-172), prioritizing same-state peers. 101 hospitals in the comp set.

HospitalStateBedsRevenueMargin
QUAKERTOWN COMMUNITY HOSPITAL (Target)PA86$146.5M5.0%
THE GETTYSBURG HOSPITALPA76$341.8M18.4%
ST. JOSEPH MEDICAL CENTERPA132$334.8M13.2%
EPHRATA COMMUNITY HOSPITALPA115$291.8M3.8%
THE GOOD SAMARITAN HOSPITALPA145$269.5M-5.0%
AMERICAN ONCOLOGIC HOSPIALPA100$229.8M-11.1%
EVANGELICAL COMMUNITY HOSPITALPA119$223.6M5.1%
ST. LUKES HOSPITAL - MONROE CAPA98$221.8M7.8%
HERITAGE VALLEY BEAVERPA148$220.0M-15.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $10.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.1M+210bp18mo
Cost to Collect4.5%2.5%$2.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.8M+122bp9mo
Clean Claim Rate88.0%96.0%$94K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.1M
Cost to Collect
$2.9M
Denial Rate Reduction
$2.9M
A/R Days Reduction
$1.8M
Clean Claim Rate
$94K
Total EBITDA Uplift$10.8M
Current EBITDA$7.3M
+ RCM Uplift+$10.8M
Pro Forma EBITDA$18.1M
Current Margin5.0%
Pro Forma Margin12.4%
WC Released (1x)$5.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$11.3M$156.3M13.83x69.1%
Base (11x exit)10.0x11.0x$11.3M$175.6M15.53x73.1%
Bull Case9.0x11.0x$10.2M$214.8M21.12x84.0%
Bull (12x exit)9.0x12.0x$10.2M$237.3M23.33x87.8%
Bear Case11.0x10.0x$12.4M$98.7M7.94x51.3%
Bear (11x exit)11.0x11.0x$12.4M$112.6M9.06x55.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 101 hospitals with 43-172 beds
  • Same-state prioritization (n=102)
  • Comp margins: P25=-19.0% / P50=-4.5% / P75=8.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.